Mizuho Securities USA’s Teva Pharmaceuticals TEVA Stock Holding History

Mizuho Securities USA’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-25,000	Closed	-$608K	–	212
2018 Q2	$608K	Buy	+25,000	New	+$510K	0.06%	112
2017 Q1	–	Sell	-92,700	Closed	-$3.36M	–	243
2016 Q4	$3.36M	Buy	92,700 +60,200	+185%	+$2.4M	0.14%	56
2016 Q3	$1.5M	Buy	+32,500	New	+$1.7M	0.12%	103
2016 Q1	–	Sell	-78,200	Closed	-$5.13M	–	157
2015 Q4	$5.13M	Buy	+78,200	New	+$4.83M	0.64%	23

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

HCM

Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Mizuho Securities USA's TEVA Position: Q3 2018 in Review

Mizuho Securities USA sold out of Teva Pharmaceuticals (TEVA) in Q3 2018, closing a stake of 25,000 shares — an estimated $608K sold.

Mizuho Securities USA first reported a position in TEVA in Q4 2015 and held it in 4 quarters. The position peaked at $5.13M in Q4 2015. 556 funds tracked by Wall St. Rank hold TEVA as of Q3 2018.

Mizuho Securities USA reported no remaining Teva Pharmaceuticals position as of Q3 2018 after selling out during the quarter.
Mizuho Securities USA sold 25,000 Teva Pharmaceuticals shares in Q3 2018, an estimated $608K.
Mizuho Securities USA first reported a position in Teva Pharmaceuticals in Q4 2015 and held it in 4 quarters.
Mizuho Securities USA's Teva Pharmaceuticals position peaked at $5.13M in Q4 2015.
556 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2018.

Based on Mizuho Securities USA's 13F filing for Q3 2018, filed 18 Oct 2018.